Interactions of malnutrition and immune impairment, with specific reference to immunity against parasites by HUGHES, S & KELLY, P
 
© 2006 The Authors 
 
577
 
Journal compilation © 2006 Blackwell Publishing Ltd
 
Parasite Immunology
 
,
 
 
 
2006, 
 
28
 
, 577–588 DOI: 10.1111/j.1365-3024.2006.00897.x
 
 Blackwell Publishing Ltd
 
REVIEW ARTICLE
 
Malnutrition and Immunity
 
Review Article
 
Interactions of malnutrition and immune impairment, with speciﬁc 
reference to immunity against parasites
 
S. HUGHES & P. KELLY
 
Tropical Gastroenterology and Nutrition Group, University of Zambia School of Medicine, Lusaka, Zambia
 
KEY POINTS
 
1C linical malnutrition is a heterogenous group of disorders
including macronutrient deﬁciencies leading to body cell
mass depletion and micronutrient deﬁciencies, and these
often coexist with infectious and inﬂammatory processes
and environmental problems.
2 There is good evidence that speciﬁc micronutrients
inﬂuence immunity, particularly zinc and vitamin A. Iron
may have both beneﬁcial and deleterious effects depending
on circumstances.
3T here is surprisingly slender good evidence that immunity to
parasites is dependent on macronutrient intake or body
composition.
 
INTRODUCTION
 
It is well recognized that the relationship between malnutrition
and infection is an intimate one, and it is often assumed that
this is because of impaired immune function. Management
guidelines for treatment of malnutrition in children explicitly
recognize that treatment of overt and occult infection is a
ﬁrst step in breaking the cycle of infection, malnutrition,
and immune impairment. In this review, we shall explore
one direction of this complex interaction by trying to
answer the question ‘what is the effect of malnutrition on
immunity?’ We will deal only with undernutrition, not with
the immunological consequences of overnutrition. We must
also point out that there are simply too few data to permit
us to analyse the impact of each type of nutritional deﬁ-
ciency on the many pathways involved in immunity against
parasites. Instead, we will try to draw broad conclusions
from such information as does exist.
We  can restate the above question by considering some
recent observations on the pathogenicity of two protozoa.
In the course of a randomized controlled trial of the effect
of an elemental diet on the outcome of severe diarrhoea–
malnutrition in Zambian children (1), we submitted faecal
samples for parasitological analysis at the beginning and at
the end of the trial. For 1 month, 200 children were treated
with either routine nutritional rehabilitation or an elemental
diet (i.e. a diet in which all the macronutrients are broken
down to amino acids, oligosaccharides and simple lipids).
At the beginning of the trial all these children had persistent
diarrhoea, which was an entry criterion. At the end of the
trial all 161 survivors were free of diarrhoea. But the preva-
lence of pathogenic protozoa was only modestly reduced at
the end of the trial compared to the baseline coprological
analysis. Initially the prevalences of 
 
Cryptosporidium
parvum
 
 and 
 
Giardia intestinalis
 
 were 24% and 6%, respectively,
but after treatment they were 13% and 8%, respectively
(M. Mwiya and S. Sianongo, unpubl. obs.). In other words,
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children with persistent diarrhoea who had had pathogens
at the beginning of the trial became convalescent carriers.
This recovery from diarrhoea was very likely to have been
due to a nutritional intervention even though the protozoa
were still present. There is very good evidence to attest to
the fact that these species are pathogenic and in this and
other studies 
 
C. parvum
 
 has been shown to be an independ-
ent predictor of mortality. We are led to conclude that
improving nutrition restored some aspect of host defence,
and this somehow improved the barrier function of the
intestinal mucosa against potential pathogens. Thus, the
expression of virulence is to some extent determined by host
defences, and this can be modulated by nutritional status.
So our question becomes three. First, what are the major
immunological defects in malnutrition that might increase
susceptibility to parasitic infection? Second, what is it in the
immune response that improves on nutritional rehabilitation?
Third, which nutrients are most important for any of these
effects? We will begin with a sketch overview of immunity
against parasites and what we mean by ‘malnutrition’, then
consider these three questions in turn.
 
OVERVIEW OF PARASITE IMMUNITY
 
While other articles in this edition will cover much of this
subject in more detail, we will sketch out the salient features
of immunity against parasites in order to provide a framework
in which failure in malnutrition can be considered. Prevention
of infection relies predominantly on barrier function and
innate immunity, whereas clearance of an established infection
requires either a successful humoral response (e.g. trypano-
somiasis) or a successful cell-mediated immune response
(e.g. schistosomiasis).
Parasite immunity builds up gradually, with the most
severe complications generally apparent in the youngest and
immunologically naïve. As immunity develops through
repeated exposure, disease and infection become less
common. For example, in malaria, immunity leads to
protection from death by 5 years, but infection leading to
asymptomatic parasitaemia occurs well into adult life (2).
The mechanisms of immune-mediated resistance to disease
and to infection remain an area of great interest but of
limited understanding. The initial encounter between host
and parasite usually involves inoculation or penetration into
the bloodstream, or contact with a mucosal surface. In the
ﬁrst of these, the blood- or lymph-dwelling forms are exposed
to soluble molecules and phagocytic cells. In the second,
penetration into mucosal cells, for example in the intestine,
immediately exposes the penetrating stage of the parasite to
epithelial cells and to dendritic cells (DCs) in the Peyer’s patch.
The initiation of immune responses requires recognition
of ligands on the parasite by receptors of the innate immune
system or of the adaptive immune system. The sensory arm
of innate defence pathways includes receptors on cells such
as macrophages, neutrophils, and natural killer (NK) cells,
including macrophage mannose receptor, scavenger receptors
and Toll-like receptors (TLRs), and soluble receptor
molecules (mannose-binding lectin, MBL, and complement).
MBL deﬁciency has been associated with cryptosporidiosis
(3) and probably with malaria (4). The sensory arm of the
adaptive immune system includes the B-cell receptor
(immunoglobulin) and the T-cell receptor for which the
ligand is antigen presented by HLA molecules on antigen-
presenting cells. Ligands of innate immune receptors (i.e.
T-cell-independent immune responses) are molecules
characterized by repeated motifs that are recognized in a
class-speciﬁc manner, so-called pathogen-associated molecular
patterns (PAMPs). Thus, innate immune receptors recognize
prokaryotic and viral molecules that exhibit these repetitive
patterns. The receptors that recognize these motifs are referred
to as pattern recognition receptors and they are ‘hard-wired’
into the genome.
Ligands of adaptive immune receptors do not display
such molecular conformity and can distinguish more subtle
nonself molecular characteristics such as speciﬁc protein
sequences. Dendritic cells possess multiple innate receptors
and interact with multiple cell types before committing
speciﬁc T cells to activation. DCs are thus at the interface of
innate and adaptive immunity and their signalling to T cells
determines the type of immune response that will be generated.
Their capacity to receive signals from both systems largely
explains how adjuvants (which are ligands for innate
receptors) augment adaptive immunity. There is emerging
evidence that parasite components can interact with TLRs
and thus with innate immunity. 
 
Schistosoma
 
  egg antigen
regulates DC activation in response to TLR activation (5),
 
Plasmodium
 
 haemozoin activates TLR9 (6), and 
 
C. parvum
 
interacts with TLRs 2 and 4 (7).
Innate effector mechanisms include phagocytosis, NK cell
killing, complement-mediated lysis and opsonization, and
antimicrobial peptides. Much more remains to be learned
about all these elements in defence against parasites as they
have received much less attention from immunologists than
adaptive immune responses. What is beyond doubt is that
the capacity to overcome or subvert innate host defences
(for example, complement by parasites (8)) is an important
element of pathogenicity (9). At mucosal surfaces, this can
be recognized as crossing the epithelial barrier. With certain
exceptions, such as toxin-secreting organisms, a pathogen
could be deﬁned as an organism that has escaped the
compartmentalization of host and commensal through
by-passing innate defences.
Adaptive immune elements include antibody responses,
particularly IgG that has a modest role in clearance and 
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protection against 
 
Plasmodium, Toxoplasma, Trypanosoma
 
,
and CD4 T-cell responses that are the dominant responses
in clearance and protection against the above and against
 
Leishmania
 
 and 
 
Schistosoma
 
 spp. IgE-dependent mast cell
and eosinophil responses play a major role in expulsion of
helminths. CD4 T cells in small intestinal epithelium have
been shown, at least in adoptive transfer experiments in
mice, to play a major role in clearance of 
 
C. parvum
 
 (10).
Both innate and adaptive systems can lead to inﬂammation,
but inﬂammation is not the dominant response to metazoan
parasites, which relies on speciﬁc pathways of clearance.
 
MEANING OF ‘MALNUTRITION’
 
The term ‘malnutrition’ describes any disorder resulting
from an inadequate or unbalanced diet, or a failure to
absorb or assimilate dietary elements. It is a broad term and
can even refer to overnutrition. But in terms of the health of
populations in tropical countries and their susceptibility to
infectious disease, we are interested in the effects of inade-
quate intake or absorption/assimilation of macronutrients and
micronutrients. Macronutrients, present in the diet in gram
or kilogram quantities, are the constituents of body tissues,
carbohydrate, proteins, fats and nucleic acids (though
deﬁciency of nucleic acids has not been described).
Micronutrients are present in much smaller quantities
(milligram or microgram) and are required for speciﬁc
metabolic functions. Examples of micronutrients are
vitamins, and minerals such as calcium, iron, zinc, copper,
selenium, and iodine.
Assessment of nutritional status is a complex subject
beyond the scope of this article, but it can be divided into
three elements: assessment of diet, assessment of body
composition, and assessment of micronutrient status. As
malnutrition has such a profound effect on functional
performance, many nutritionists would also add that
assessment of function (such as muscle strength, cognitive
ability, quality of life) should be included.
Separate syndromes of severe malnutrition are recog-
nized: severe wasting (marasmus), oedematous malnutrition
(kwashiorkor), and the coexistence of oedema with severe
wasting (marasmic kwashiorkor). Severe malnutrition is a
result of two dominant processes: primary malnutrition
(food deprivation) usually as a result of conﬂict or famine,
and secondary malnutrition resulting from infectious,
inﬂammatory, or malignant disease leading to anorexia and/
or increased nutrient demand. In both of these situations,
peripheral oedema may supervene but its pathogenesis is
not understood and it is not clear if the presence of oedema
has any implications for host defence. As medical/scientiﬁc
research is carried out in peacetime in fairly stable settings,
most of the work on host defence in malnutrition in humans
has failed to dissect out the consequences of macronutrient
and/or micronutrient depletion and the infectious and
inﬂammatory processes that gave rise to it. This is a serious
problem in the literature.
 
WHAT ARE THE MAJOR IMMUNOLOGICAL 
DEFECTS IN MALNUTRITION?
 
There is a very large body of literature that attempts to
deﬁne immunological dysfunction in malnourished patients,
which we will deal with here, though probably the best
evidence comes from intervention studies (see below).
Studies reporting the ﬁndings in cohorts of children with
severe malnutrition are difﬁcult to integrate, as the studied
groups are often incompletely described and when described
well, clearly far from homogenous. There are difﬁculties in
the deﬁnition of malnutrition, the identiﬁcation of cause,
and the comprehensive description of concurrent infections,
which are often hidden yet are critical confounders. With
more complex testing procedures, problems also exist with
the deﬁnition of normal ranges for age-matched and infection-
matched controls. Future studies will need to describe very
carefully the groups studied with particular attention to
infectious diseases, and have control data clearly identiﬁed
to reduce bias and aid interpretation.
Our work in Lusaka addresses children and adults with
malnutrition, HIV, and a broad spectrum of infectious
diseases and gastrointestinal pathologies. In one recent study,
we were not able to conﬁdently identify a single case of primary
malnutrition in a cohort of 84 severely malnourished children,
as all had presented with history of either lengthy diarrhoeal
disease, or pulmonary disease or were found to be HIV infected.
The most compelling evidence that malnutrition is
associated with immunodeﬁciency comes from the descrip-
tions of the infections in severe malnutrition. However, it
must be remembered that infections are as much a cause of
malnutrition as a consequence, and errors can be made
ascribing cause and effect. Infection itself is known to have
a negative effect on immunocompetence. Regarding
infections in the severely malnourished, two additional facts
must be considered. First, infection plays a very major role
in the clinical presentation of severe malnutrition. Second,
infection is often silent, as the febrile response to infection
is often inadequate.
Many authors have aimed to study primary malnutrition,
yet this is difﬁcult. As an alternative, the most ‘pure’ form
of human undernutrition amenable to study is anorexia
nervosa. Although susceptibility to infectious disease is less
in anorexia nervosa than in other forms of undernutrition
(11), IL-2 synthesis was reduced by 49% in one study (12).
However, T-lymphocyte populations were normal and
lymphocyte proliferation in response to phytohaemagglutinin 
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and concanavalin A was if anything increased (11). High
circulating levels of IL-1
 
β
 
  and TNF-
 
α
 
  were  observed in
another study, together with reduced T-cell activation as
expressed by CD2 and CD69 (13). These ﬁndings and others
listed below leave us with considerable uncertainty as to
whether it is the malnutrition 
 
per se
 
 that leads to the immune
defects we describe, and in later sections we ask whether
nutritional treatment can restore immune function.
Before examining the impact of malnutrition on elements
of the immune system, it is important to ﬁrst recognize that
susceptibility to infection and associated mortality depends
on other host factors also. Various aspects of barrier
function become deranged in malnutrition, for example
gastric acid secretion is reduced, leading to increased
susceptibility to intestinal infection (14).
There is agreement that malnutrition worsens prognosis
in AIDS patients (15), and in Lusaka we have conﬁrmed
that low body mass index is an independent predictor of
death in the short term in patients with AIDS-related
diarrhoea (16). Macronutrient support can improve survival
in severely malnourished AIDS patients (17). However, it is
not clear if this is an effect on immunological function.
Substantiation of malnutrition-related immunodeﬁciency
is assembled from three distinct evidence bases.
1 Increased incidence or severity of infections. It should
be noted that without evidence of increased susceptibility
to, or severity of, infectious disease, abnormalities in laboratory
assessments do not constitute an immunodeﬁciency.
2 Markers of immunodeﬁciency (laboratory or clinical,
some of these are well validated, others much less so).
3
 
In vitro
 
  functional analysis of immune processes, i.e.
dynamic assays.
Selected evidence, from studies of malnourished human
subjects, for and against a malnutrition-associated immun-
odeﬁciency is presented in Table  1. Where possible, data
have been collected from longitudinal nutrition intervention
studies. Where this has not been possible, observational studies
have been cited. The data represent well the breadth and
depth of published ﬁndings, though the list of citations is
not comprehensive.
It is clear that there is much circumstantial evidence in
support of malnutrition-associated immunodeﬁciency, but
some evidence against it, and much uncertainty regarding
cause and effect. Given the maelstrom of immune defects, it
is tempting to consider these many elements of immune
dysfunction as evidence of dysregulation rather than
immunodeﬁciency; however, the disturbed processes remain
to  be uncovered. In addition, against classical immune
 
Table 1
 
Evidence for elements of immunodeﬁciency in cases of malnutrition
Issue Reported ﬁnding Population studied References
Infections
 
Pneumocystis jirovecii pneumonia
 
High prevalence SM – autopsy studies 18,19
 
Mycobacterium tuberculosis
 
 infection High prevalence SM – autopsy study 18
‘Dissemination of disease’ including 
miliary and CNS tuberculosis
SM 20
Herpes viruses High prevalence SM – autopsy study 18
Acute respiratory tract infection High prevalence MM 21
Diarrhoea High prevalence MM 22
Malaria Morbidity and mortality attributable 
to undernutrition
Malaria-infected cohorts 23
Reduced risk of cerebral malaria 24
Leishmania Malnutrition predisposes 
to visceral leishmaniasis
MM 25
Infection frequency No increase AN 11
Markers of immunodeﬁciency
Thymolymphatic atrophy Reduced bulk on autopsy SM – autopsy studies 18,26
Reduced bulk in life SM (infected) 27
Tonsil size Smaller size MM, SM (infected) 26,28
Low leucocyte count Present Kwashiorkor 29
Absent AN 11
Low lymphocyte count Present AN, SM, MM 13,28,30
Absent AN, SM 11,31
Low T-cell count Present SM 27,30,32
Absent SM, AN 11,33,34
Low CD4 cell count Absent AN, SM 11,13,27,34
Present Kwashiorkor, ‘malnourished’ 27,32
Antibodies Raised levels SM 33,35
Lowered levels AN 13 
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Speciﬁc antibody defects Normal levels MM 36
Disparate results from Varying groups 37
different studies
Secretory IgA Reduced levels SM 38
Raised production Kwashiorkor 39
Acute phase protein response Impaired responses SM 40
Unimpaired responses SM 41,42
Complement Reduced levels of haemolytic SM, kwashiorkor, mild 28,31,33,43
complement, reduced and moderate malnutrition
C3 and C4, reduced C3
Normal levels AN 11
Functional testing
Neutrophil function Impaired phagocytosis SM 44,45
Normal or improved MM and SM 46
Opsonization and phagocytosis
Impaired microbicidal activity MM and SM 45,46,47
Impaired chemotaxis SM 45
Monocyte function Reduced cytokine (IL1,  SM 31,48,49
TNF
 
α
 
) production
Reduced phagocytosis of candida SM 31
Reduced lysis of candida SM 31
T-cell function Diminished Mantoux recall SM 50
responses
Impaired BCG sensitization Kwashiorkor 51
Diminished multitest skin  MM 21
Cell-mediated immunity (CMI) test
Partially impaired CMI AN 11
Reduced dinitrochlorobenzene SM (infected), SM 26,30
sensitization
Reduced phyto(haem)agglutinin SM, AN, MM 13,26,28,45,52
(PHA) mitogenesis
Increased PHA mitogenesis AN 11
B-cell function (vaccine challenge 
and speciﬁc antibody responses)
Normal levels MM 36
AN, anorexia nervosa; MM, moderate malnutrition; SM, severe malnutrition.
Issue Reported ﬁnding Population studied References
 
dysregulation, there is no evidence of allergic disease in the
severely malnourished and rarely is there a suggestion of
autoimmune pathology.
Early data from our work in Lusaka suggest that DC
function, which has not previously been addressed, may also
be important, and may underlie some of the dysregulation
described above. One child, a girl aged 20 months presented
with a 3-month history of diarrhoea and a 5-day history of
sores in the mouth, fever and cough. She was emaciated,
and had pedal oedema. Her weight-for-height 
 
z
 
 score on
admission was 
 
−
 
3·61. She made a rapid recovery from her
malnutrition and her diarrhoea ceased during her admission.
Laboratory examination of her DCs on admission and then
on recovery (Figure 1) identiﬁed a low DC count initially,
which had risen at the time of her discharge. In concert with
this ﬁnding was the discovery that she had an unusual
phenotype to her cultured DC population. On stimulation
with lipopolysaccharide (LPS), in contrast to normal
phenotype, her DCs downregulated HLA-DR and CD86.
Downregulation of HLA-DR expression reduces DC
capacity to support a protective T-cell response to threat,
thereby disabling the immune response.
 
WHICH ELEMENTS OF THE IMMUNE 
RESPONSE RESPOND TO GLOBAL 
NUTRITIONAL REHABILITATION?
 
Standard nutritional rehabilitation for severe malnutrition
now begins with blind antibiotic therapy, though in the past
this was not routine. We have selected studies in which
primary malnutrition was treated with nutritional therapy
alone, though in many studies we cannot be certain that
antibiotics were not given. Studies conﬁrm that the initial
ﬁnding of thymolymphatic atrophy resolves with renutrition
(53), and in parallel, T-lymphocyte function as examined by
cell proliferation and the tuberculin test improves (28,45,52).
Note however, that repeated tuberculin tests will improve
responses through the process of ‘vaccination’ alone. In
addition, described defects of the innate immune system,
such as complement levels (43), neutrophil microbicidal
 
Table 1
 
Continued 
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Figure 1 Evidence of depletion of dendritic cell (DC) number s and dysfunction of DCs in the child whose case is described in the text. A and 
B FACS (ﬂuorescence activated cell sorter) plot of peripheral blood mononuclear cells (PBMCs) after initial selection by side scatter and CD45 
expression. Each point represents one PBMC, and the intensity of staining with lineage markers (CD3, CD14, CD16, CD19, CD56) is shown 
on the x axis. DCs have little or no staining for these markers. HLA-DR staining is shown on the y axis; DCs have high DR staining and the 
box therefore includes those cells tha are likely DCs. A FACS plot on admission; B just prior to discharge, after good nutritional recovery and 
DC numbers have increased from 0·32% to 0·84% of PBMCs. C and D histograms of cultured DCs at rest (blue shading) and after stimulation 
with lipopolysaccharide (open histogram delineated by black line) which is expected to stimulate DCs; isotype control is shown as green 
histogram. C cells from admission sample fail to upregulate HLA-DR, but D after nutritional recovery the capacity to upregulate HLA-DR 
is restored. 
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activity (45), secretory capacity for IgA transport into
secretions (54), and monocyte production of cytokines
(IL1
 
β
 
, TNF
 
α
 
, and IL6) (40,48), all improve on renutrition.
 
WHICH NUTRIENTS COULD BE 
RESPONSIBLE FOR ANY IMPROVEMENT?
 
Macronutrients
 
Clinical trials of nutritional rehabilitation and immune
function are few. Although there are many trials of nutrition
interventions and their effect on infectious disease, trials
that show a successful improvement in nutritional status and
a subsequent effect on measures of immunological function are
very few. In one of the studies in anorexia nervosa referred
to above, nutritional rehabilitation returned the increased
mitogen responsiveness towards normal (11). Cytokine
perturbations also returned to normal after re-feeding (13),
but in both of these instances it is not possible to dissect out
the inﬂuence of macro- and micronutrients.
In a trial in which Kenyan school children were rand-
omized to several different food supplementation foods (meat-
based, milk-based, vegetable oil-based or none), antibody
titres to 
 
Helicobacter pylori
 
, rotavirus, tetanus toxoid and
malaria merozoite surface proteins showed very little
change (55).
The effect of nutritional therapy on malaria has been
unclear ever since the Murray team found in the 1970s that
undernutrition protected against morbidity and mortality
(24). This unexpected ﬁnding was borne out by studies in
protein-deprived animals. Subsequent work has not really
supported this contention, and a recent WHO analysis has,
characteristically, attempted to quantify the proportion of
malaria attributable to malnutrition (23). This more
comfortable reading suggests that micronutrient deﬁciency
plays a more signiﬁcant role in immunity to malaria than
macronutrient deﬁciency. However, we believe that the
earlier work cannot be ignored, especially as it was carried
out in a famine situation, which is a more ‘pure’ form of
primary malnutrition.
It is well established that survival in AIDS is determined
to a considerable degree by nutritional status (both macro-
nutrient and micronutrient), and if this is through an effect
on immune function one would expect to see improvements
in CD4 count if weight gain can be achieved. Despite a
careful search of several databases, no evidence for an effect
of treatment using macronutrients on immune function in
AIDS could be found (see also Macallan (15)). For example,
parenteral nutrition improved nutritional status (body
composition) compared to controls, but no assessment was
made of immune function (17). There is no evidence that
lipid supplementation is of beneﬁt (56,57).
If there is a relationship between body composition and
immune function, it might be mediated by leptin (58).
Leptin is a 16 kDa protein hormone that was discovered as
the missing gene product in the 
 
ob/ob
 
 obese mouse. Leptin,
produced by adipose tissue, acts as a satiety signal: high
levels are associated with body fat and levels decrease as fat
tissue is lost during starvation. The leptin receptor has
structural similarities to the IL-6 family of cytokines and
leptin signalling is inhibited by SOCS-3 that regulates other
cytokines. Macrophages from leptin-deﬁcient mice are
constitutionally activated and over-react in response to LPS,
but their killing of 
 
Escherichia coli
 
 is impaired. Leptin-
deﬁcient mice also have lymphopenia and impaired delayed-
type hypersensitivity (DTH). It is thus tempting to speculate
that low circulating leptin in humans with wasting would
lead to such T-cell and macrophage defects seen in both 
 
ob/
ob
 
 mouse and in starved mice. There is evidence in 
 
ob/ob
 
and starving mice that the immune dysfunction is mediated
by leptin as leptin reverses the dysfunction (59). However,
this has not been shown in humans, and the link between
macronutrient depletion and the immune dysfunction
remains tentative.
 
Vitamin A
 
It has been clear that vitamin A has important anti-infective
properties since 1932 when it was shown that it reduced case
fatality from measles. Large studies in Ghana, Indonesia
and elsewhere have conﬁrmed that vitamin A has important
effects in reducing adverse outcome from infectious disease
in underdeveloped countries, particularly diarrhoea and
measles (60). There are also two relevant clinical trials of the
effect of vitamin A supplementation on malaria. The ﬁrst, in
Ghana, found no beneﬁt on malaria morbidity (61), but the
second, in Papua New Guinea (62), showed reduced malaria
morbidity in children supplemented with vitamin A
compared to placebo (relative hazard 0·70, 95%CI 0·57–
0·87). Vitamin A supplementation may reduce placental
infection (63). However, the outstanding question is: is this
an effect on immune function or on some other aspect of
host defence such as epithelial integrity?
In laboratory animals, vitamin A polarizes the immune
response towards Th2 (64,65), acting through retinoic acid,
its principal oxidative metabolite. Retinoic acid also boosts
the antitetanus antibody response (66). However, evidence
of an immune booster effect in humans is much less clear.
This evidence has recently been thoroughly reviewed (67).
To summarize this evidence (67), there is evidence that intes-
tinal epithelial integrity is improved by vitamin A (68), but
not of improved antimicrobial properties in breast milk, and
no evidence of improved barrier function in the vagina.
There is very preliminary evidence of reduced secretion of 
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TNF-
 
α
 
  and IL-6 when challenged by speciﬁc pathogens.
There is some evidence of a beneﬁcial effect in raising CD4
counts in HIV-infected children but not in adults. Neither is
there conclusive evidence of effects on cytokine production
or lymphocyte function, but antibody responses to tetanus
toxoid may be enhanced if the vitamin A is given before the
vaccine (67). When contrasted with the highly signiﬁcant
effects of vitamin A in reducing childhood morbidity and
mortality, particularly from measles and diarrhoea, the very
uncertain evidence of effects on immune competence is
striking. It seems likely on the basis of current evidence that
epithelial or barrier integrity is an important part of the
effect of vitamin A. Furthermore, addition of a vitamin A
supplement to a supplement of vitamins B, C, and E given
to HIV-infected pregnant women detracted from the beneﬁt
attributable to the supplement (69) so the effects of vitamin
A, even if mediated by augmented cell-mediated immunity,
are complex and can be disadvantageous.
 
Zinc
 
There is abundant clinical evidence that zinc is a critically
important nutrient for the proper functioning of the immune
system. Zinc is effective in prevention of diarrhoea: a recent
review [6] of nine trials showed signiﬁcant reductions in
diarrhoea incidence, and all showed a reduction of some
magnitude (70). Similar beneﬁts were also found for
pneumonia and malaria, though fewer trials are available
for analysis. Zinc also gives a 42% (95%CI 10–63%)
reduction in treatment failure or death from diarrhoea (71),
though high doses may be detrimental (72). A meta-analysis
of clinical trials of zinc supplementation in prevention of
malaria concluded that a reduction in incidence of 36%
(95%CI 9–55%) might be possible (23), but in one trial,
there was no beneﬁt on malaria incidence or severity at all
(73). Thus, it appears that zinc supplementation is clinically
effective in reducing morbidity and mortality due to
diarrhoeal disease and malaria in children. But is this an
effect on immunity or host defence or something else?
There are two lines of evidence that suggest that zinc
deﬁciency adversely affects immune function and that
supplementation improves it. First, in humans there are data
from the 1970s which, though not conclusive, support this
contention. Children with acrodermatitis enteropathica, a
congenital defect of zinc absorption, have thymic atrophy,
lymphopenia, reduced lymphocyte response to mitogens,
reduced DTH, and reduced immunoglobulin responses (74).
Many other reports of immune defects in zinc-deﬁcient
patients are difﬁcult to interpret because of comorbid
processes (e.g. renal failure) which could themselves impair
immunity. But in an important study in Indian children with
diarrhoea, zinc supplementation increased numbers of
circulating CD3 and CD4 cells, but not CD8 cells, B cells or
NK cells (75). In terms of innate immunity, Paneth cells,
which synthesize antimicrobial molecules for innate defence
of the small intestine in humans, are also dependent on zinc
(76,77). Second, zinc deprivation of mice for as little as
30 days reduced cell-mediated immunity, DTH, antitumour
immunity, and antibody responses by up to 80% (78).
Challenging zinc-deﬁcient animals with low doses of
 
Trypanosoma cruzi
 
 or intestinal nematodes resulted in death
(79). The deﬁciency state was associated with reduced
numbers of lymphocytes due to impaired lymphopoiesis, but
the production of antibody by each cell was not impaired.
Furthermore, while zinc deﬁciency had marked effects on
lymphoid cells, there was no effect on myeloid cells, and this
lead Fraker 
 
et al
 
. (78) to advance a fascinating and
potentially very important theory. This is that maintenance
of lymphocyte populations is very expensive in terms of zinc
and other nutrients, and that in the face of nutritional stress
innate defence is maintained at the expense of adaptive
immune responses. The Fraker theory is very attractive and
deserves much further work. If true, the ramiﬁcations for
management of infectious disease in malnourished patients
could be considerable.
However, there is evidence that NK cell function and
phagocytosis by macrophages are also impaired in zinc
deﬁciency, and this may be a consequence of reduced
oxidative burst capacity, for example in trypanosomiasis
(80). Zinc supplementation of mice during 
 
Plasmodium berghei
 
infection reduced markers of oxidative stress (81), but the
signiﬁcance of this is not clear. Zinc itself induces release of
IL-1, IL-6, TNF-
 
α
 
, and IFN-
 
γ
 
 in macrophages but not T
cells, and high supraphysiological concentrations suppress
T-cell functions (82). Early data suggest that zinc is impor-
tant for maintenance of antimicrobial peptide delivery in the
small intestine (77,83).
The most deﬁnitive evidence that zinc deﬁciency is critical
for immune function in humans comes from experimental
zinc deﬁciency induced by dietary restriction in human
volunteers (84). Deﬁciency reduced thymulin levels in blood,
and reduced the CD4/CD8 ratio. Zinc deﬁciency also
reduced synthesis of Th1 cytokines IL-2 and IFN-
 
γ
 
, but
not the Th2 cytokines IL-4, IL-6, and IL10. NK cell activity
was also reduced in the volunteers on a zinc-deﬁcient diet.
 
Iron
 
In studies in iron-deﬁcient humans, iron deﬁciency has been
associated with defects in both adaptive and innate immunity,
and these are reversible with iron therapy (85). Adaptive
immune defects include reduced T-cell numbers, reduced T-
cell proliferation, reduced IL-2 production by T cells, reduced
MIF production by macrophages, and reduced tuberculin 
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skin reactivity. Innate immune defects include reduced
neutrophil killing, probably due to reduced myeloperoxidase
activity and impaired NK cell activity.
However, the picture is far from simple. Lactoferrin in
human milk chelates iron and inhibits bacterial proliferation
by depriving the bacteria of an essential nutrient. The
bacteriostatic effect of human milk is abolished by iron
therapy (86), so that iron therapy would be expected to
increase neonatal intestinal infectious disease. In milk-drinking
nomads, iron therapy was associated with an increase in
 
Entamoeba histolytica
 
 infection, possibly due to saturation
of the milk transferrin that overcomes the protective effect (87).
The same group had previously noted recrudescence of
malaria and schistosomiasis in nomads treated with iron
(88). An overview of iron supplementation studies in malarious
regions included 11 trials (85). Five of nine trials in which
clinical malaria was assessed showed a deleterious effect,
and no trials showed beneﬁt. Respiratory infections and
other infectious morbidity were also, if anything, increased
(though diarrhoeal disease was not). A recent observational
study in Kenya (89) indicated that the incidence of clinical
malaria was lower among iron-deﬁcient children (IRR 0·70,
95%CI 0·51–0·99). This deleterious effect of iron supple-
mentation on infectious disease has not been observed in
clinical trials in nonmalarious regions (85), though there is
evidence that dialysis and multiply transfused patients with
iron overload have immune defects (90). Finally, and fairly
conclusively, a recent large study seems to conﬁrm previous
observations that iron supplementation worsens infectious
disease morbidity and mortality by 11–15% (91) and, taken
together, the evidence is that this effect is real and important.
In summary, it is difﬁcult to draw a ﬁrm conclusion as to
whether iron status contributes to the impaired immunity to
parasites seen in malnutrition. There is evidence of T-cell
and innate immune impairment in iron deﬁciency, but
supplementation (i.e. supraphysiological intakes of iron)
seems to worsen susceptibility to malaria and possibly to
other infectious diseases.
 
Other antioxidant molecules
 
Selenium is an important antioxidant that has been shown
to have wide-ranging immunostimulant effects in macrophages
and T and B cells in humans (92). However the evidence for
this rests on a very small number of primary publications
(93,94). The most compelling recent evidence is an example
of the sort of functional immunological testing that is all too
rare in this ﬁeld (95). Twenty-two British volunteers with
low plasma selenium concentrations were given modest
doses of a selenium supplement (up to 100 
 
µ
 
g/day) or placebo,
then were challenged with oral polio vaccine and immune
responses to the vaccine determined (95). Selenium
supplemented volunteers showed increased T-cell proliferation,
and higher interferon-
 
γ
 
  and IL-10 production by T cells
7  days after vaccination. They also showed more rapid
clearance of the virus from stool. The situation is very
similar for vitamin E, in which there is much interest, but for
which the evidence base is narrow. In one clear-cut study in
elderly people, vitamin E supplementation for 4  months
increased DTH responses and increased antibody titres to
clinically relevant vaccines (hepatitis B, tetanus) but not
immunoglobulin levels or T or B cell numbers (96). There
are no data to our knowledge of the effect of these micronu-
trients speciﬁcally on immune responses to parasites, but
these data suggest that antioxidant nutrients are likely to be
important in maintaining immunity.
 
CONCLUSIONS
 
There is evidence that malnutrition impairs elements of
adaptive and innate immunity which would be important
for defence against parasitic infections, although evidence of
increased incidence or severity of parasitic infections in
malnourished humans is fairly limited. The evidence that
this immune dysfunction is attributable to deﬁciency of protein
or other macronutrients is weak; we ﬁnd it unconvincing
and conclude that it has been overstated in the past on the
basis of poorly controlled studies. On the other hand, there
is good evidence of links between micronutrient deﬁciencies
and immune impairment. This evidence is strongest for zinc,
deﬁciency of which leads to impairment of both innate and
T-cell responses. The evidence that antibody responses are
impaired in any malnourished state is much less convincing.
Given the very heavy burden of infectious disease around
the world, and its massive contribution to illness and
premature death, this ﬁeld warrants much greater attention.
As primary malnutrition is usually associated with famine,
conﬂicts and population displacement, and confounding
factors in secondary malnutrition are inevitable, observa-
tional studies are difﬁcult to interpret. Study of patients with
anorexia nervosa could still give much useful information on
the impact of macronutrient depletion. However, the most
useful information will be derived from speciﬁc controlled
interventions in volunteers and in patients.
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